CME Activity

Ticagrelor Removal


George O. Angheloiu, MD

Massachusetts Institute of Technology
Cambridge, Massachusetts
University of Pittsburgh Medical Center Susquehanna
Williamsport, Pennsylvania
The Heart Doctor
Lancaster, Pennsylvania

Gabriel B. Gugiu, PhD

Department of Molecular Immunology
City of Hope National Medical Center
Duarte, California

Cristian Ruse, PhD

New England BioLabs Inc.
Ipswich, Massachusetts

Rishikesh Pandey, PhD

Massachusetts Institute of Technology
Cambridge, Massachusetts

Ramachandra R. Dasari, PhD

Massachusetts Institute of Technology
Cambridge, Massachusetts

Carl Whatling, PhD

Cardiovascular and Metabolic Diseases
Innovative Medicines and Early Development Biotech Unit
Gothenburg, Mölndal, Sweden

Accredited by

American College of Cardiology

Course Description

After reading this article the reader should be able to:

- Describe the pharmacologic properties of ticagrelor versus other P2Y12 inhibitors.
- Explain the rationale for ticagrelor removal in the BSA and human removal experiments.
- Examine the potential clinical impact of effective and efficient ticagrelor removal.

Activity Details

Credit Types:CME
Credit Amount:1.00 Credits
Release Date:2017-Apr-24
Expiration Date:2018-Mar-31
Estimated Time for Completion:1 hour
Registration Required:Yes

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.